Menopause Position Statements

“If you would like to find out what menopause
position statements are applicable to you, it may be
in your best interest to choose to talk to your…”.Meno Martha

Umbrella

What may the Menopause Position Statements Umbrella include?

Depending on the Source (DotS) this Umbrella may include:

  • Clinical Guides
  • Consensus Statements
  • Final Recommendation Statements
  • Global Consensus Statements
  • Guidelines
  • Other Reports
  • Position Papers
  • Position Statements
  • Recommendations
  • Reports
  • Statements
  • White Papers

Date

Menopause Position StatementsWhat can it be important to be clear about with menopause position statements?

It can be important to be clear about the date of all information including the date of menopause position statements because this information may have been updated or retired.

Health Care Provider

What if I would like to find out what menopause position statement information is applicable to me?

If you would like to find out what menopause position statements are applicable to you, it may be in your best interest to choose to talk to your health care provider about this.

Health Topics A-Z

Where may I find Health Topics A-Z related to Menopause Position Statements?

In Health Topics A-Z you may find:

Health Topics A-Z

Links

Where may I find Links related to Menopause Position Statements?

Your Country may have Links similar to:

Links

This Links List to third party websites is neither comprehensive nor exhaustive. Inclusion on this Links List does not imply endorsement or recommendation. Non-inclusion on this Links List does not imply non-endorsement or non-recommendation. Third party websites are not under the control of Meno Martha International Menopause Directory. Third party websites may contain explicit medical images and/or sexual references. Please read Meno Martha International Menopause Directory’s Links Policy before proceeding to a Link. Please contact Webmaster if you experience a problem with a Link.

BMS   = British Menopause Society
EMAS = European Menopause and Andropause Society
IGCS  = International Gynecologic Cancer Society
IMS    = International Menopause Society

New or Updated

  1. Assessment and Management of Bone Health In Women With Oestrogen Receptor-Positive Breast Cancer Receiving Endocrine Therapy
  2. BMS & WHC’s 2020 Recommendations on Hormone Replacement Therapy In Menopausal Women
  3. BMS Council Issues A Consensus Statement on Bioidentical Hormones
  4. BMS Statement on Testosterone
  5. BMS Vision: Vision for Menopause Care In the United Kingdom
  6. BMS, IMS, EMAS, RCOG and AMS Joint Statement on Menopausal Hormone Therapy (MHT) and Breast Cancer Risk
  7. Bioidentical HRT [British Menopause Society]
  8. British Gynaecological Cancer Society (BGCS) Ovarian, Tubal and Primary Peritoneal Cancer Guidelines: Recommendations for Practice Update 2024
  9. British Gynaecological Cancer Society and British Menopause Society Guidelines Management of Menopausal Symptoms Following Treatment of Gynaecological Cancer
  10. British Menopause Society Tool for Clinicians: Testosterone Replacement In Menopause
  11. CAMS Menopause Hour: Genitourinary Health [Council of Affiliated Menopause Societies]
  12. Calcium In the Prevention of Postmenopausal Osteoporosis: EMAS Guide
  13. Cardiovascular Health After Menopause Transition, Pregnancy Disorders, and Other Gynaecologic Conditions: A Consensus Document From European Cardiologists, Gynaecologists, and Endocrinologists
  14. Cardiovascular Risk Assessment In Women – An Update
  15. Clinical Practice Guidelines on Menopause: *An Executive Summary and Recommendations: Indian Menopause Society 2019–2020
  16. Clinical Practice Guidelines on Postmenopausal Osteoporosis: *An Executive Summary and Recommendations – Update 2019–2020 [Indian Menopause Society]
  17. Compounded Bioidentical Hormones In Endocrinology Practice: An Endocrine Society Scientific Statement
  18. Consumer Video and Podcast Series: 2023 Consumer Videos and Podcasts – NAMS 2023 Nonhormone Therapies Position Statement for Bothersome Menopause Symptoms
  19. Current Management of Pelvic Organ Prolapse In Aging Women: EMAS Clinical Guide
  20. Department of Health Shares the Results of Research About Menopause In Ireland Following the First Government Led Menopause Awareness Campaign In Ireland
  21. Drug Holidays From Bisphosphonates and Denosumab In Postmenopausal Osteoporosis
  22. EMAS Position Statement: Predictors of Premature and Early Natural Menopause
  23. EMAS Position Statement: Thyroid Disease and Menopause
  24. EMAS Position Statement: Vitamin D and Menopausal Health
  25. Eligibility Criteria for Menopausal Hormone Therapy (MHT): A Position Statement From A Consortium of Scientific Societies for the Use of MHT In Women With Medical Conditions. MHT Eligibility Criteria Group
  26. Global Consensus Position Statement on the Use of Testosterone Therapy for Women
  27. Global Consensus Recommendations on Menopause In the Workplace: A European Menopause and Andropause Society (EMAS) Position Statement
  28. Global Consensus Statement on Menopausal Hormone Therapy
  29. Guidelines and Education: EMAS Position Statements
  30. Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations
  31. Hormone Therapy In Postmenopausal Persons: Primary Prevention of Chronic Conditions
  32. Info for Professionals: Clinical Practice Guidelines [Indian Menopause Society]
  33. International Society for the Study of Women’s Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder In Women
  34. Joint BMS BSGE BGCS FSRH GIRFT and RCOG Guideline on Management of Unscheduled Bleeding on HRT
  35. Joint BMS, FSRH, RCGP and RCOG Position Statement on the Supply Shortages of Hormone Replacement Therapy (HRT)
  36. Joint Position Statement By the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on Best Practice Recommendations for the Care of Women Experiencing the Menopause
  37. Management of Osteoporosis In Postmenopausal Women: The 2021 Position Statement of The North American Menopause Society
  38. Management of Postmenopausal Women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d’Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines
  39. Menopause Knowledge and Education In Women Under 40: Results From An Online Survey
  40. Menopause and Diabetes: EMAS Clinical Guide
  41. Menopause and MHT In 2024: Addressing the Key Controversies – An International Menopause Society White Paper
  42. Menopause and the Workplace: Consensus Recommendations From The Menopause Society
  43. Menopause and the Workplace: Consensus Recommendations From The Menopause Society
  44. Menopause, Wellbeing and Health: A Care Pathway From the European Menopause and Andropause Society
  45. Menopause: Diagnosis and Management [NICE Guideline In Development [GID-NG10241] Expected Publication Date: 23 August 2023]
  46. Menopause: Diagnosis and Management [NICE Guideline NG 23]
  47. NICE Sets Out Further Details on Menopause Guideline Update
  48. New Menopause Practice Standards
  49. NonHormonal Management of Menopause-Associated Vasomotor Symptoms: 2015 Position Statement of the North American Menopause Society
  50. Optimising the Menopause Transition: Joint Position Statement By the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on Best Practice Recommendations for the Care of Women Experiencing the Menopause
  51. Pharmacological Management of Osteoporosis In Postmenopausal Women Guideline Resources
  52. Position Papers and Consensus Statements [International Menopause Society]
  53. Position Statement on Improving Bone Health and Osteoporosis Management In Australia
  54. Position Statements & Other Reports [North American Menopause Society]
  55. Position Statements [Australasian Menopause Society]
  56. Premature Ovarian Insufficiency [British Menopause Society]
  57. Preventing Obesity in Midlife Women: A Recommendation From the Women’s Preventive Services Initiative
  58. Prevention and Treatment of Osteoporosis In Women [British Menopause Society]
  59. Primary Prevention of Coronary Heart Disease In Women [British Menopause Society]
  60. RCGP, RCOG and BMS Position Statement on the Menopause
  61. Revised Global Consensus Statement on Menopausal Hormone Therapy
  62. Sexual Health and Wellbeing and the Menopause: An EMAS Clinical Guide
  63. The 2020 Genitourinary Syndrome of Menopause Position Statement of The North American Menopause Society
  64. The 2022 Hormone Therapy Position Statement of The North American Menopause Society
  65. The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society
  66. The 2023 Practitioner’s Toolkit for Managing Menopause
  67. The British Menopause Society & Women’s Health Concern 2020 Recommendations on Hormone Replacement Therapy In Menopausal Women
  68. The Essential Menopause Curriculum for Healthcare Professionals: A European Menopause and Andropause Society (EMAS) Position Statement
  69. The Mediterranean Diet and Menopausal Health: An EMAS Position Statement
  70. The North American Menopause Society Releases Its 2022 Hormone Therapy Position Statement
  71. The Silence and the Stigma: Menopause In Canada
  72. The South African Menopause Society (SAMS) Statement on Compounded (Bioidentical) Menopausal Hormone Therapy
  73. Topical Estrogens and Non-Hormonal Preparations for Postmenopausal Vulvovaginal Atrophy: An EMAS Clinical Guide
  74. Use of Compounded Hormone Therapy In the United States: Report of the North American Menopause Society Survey
  75. Videos & Podcasts: Videos – Interviews: Impending Menopause: How Can Fertility Be Preserved?
  76. Webinars: Previous – Menopausal Migraines
  77. World Menopause Day 2018 – Sexual Well-Being After Menopause: An International Menopause Society White Paper [Multiply Languages]
  78. World Menopause Day 2019 – Global Consensus Position Statement on the Use of Testosterone Therapy for Women: A White Paper [Multiply Languages]
  79. World Menopause Day 2020: Premature Insufficiency: An International Menopause Society White Paper [Multiply Languages]
  80. World Menopause Day 2021: Update on Bone Health: The IMS White Paper [Multiply Languages]
  81. World Menopause Day 2022: Brain Fog In Menopause: A Health Care Professional’s Guide for Decision Making and Counseling on Cognition: The IMS White Paper [Multiply Languages]
  82. World Menopause Day 2023: The IMS White Paper – Reproductive Milestones Across the Lifespan and Cardiovascular Disease Risk In Women [Multiply Languages]
  83. World Menopause Day 2024: IMS White Paper: Menopause and MHT In 2024: Addressing the Key Controversies [Multiply Languages]
  84. World Menopause Day 2024: Leaflet for Women
    International Menopause Society
  85. World Menopause Day 2024: Poster for Women
    International Menopause Society

Topic Last Updated: 08 October 2024 – Topic Last Reviewed: 08 October 2024
Print Friendly, PDF & Email
/by